PEAK6 Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-15,626
Closed -$360K 4600
2023
Q4
$360K Buy
15,626
+2,940
+23% +$65.8K ﹤0.01% 2842
2023
Q3
$292K Sell
12,686
-901
-7% -$22.9K ﹤0.01% 2800
2023
Q2
$355K Sell
13,587
-2,389
-15% -$63.1K ﹤0.01% 2463
2023
Q1
$441K Sell
15,976
-13,119
-45% -$346K ﹤0.01% 2497
2022
Q4
$661K Buy
+29,095
New +$810K ﹤0.01% 2276
2022
Q3
Sell
-13,587
Closed -$502K 5880
2022
Q2
$355K Buy
+13,587
New +$345K ﹤0.01% 4187

Other funds holding PRVA

PEAK6 Investments's PRVA Position: Q1 2024 in Review

PEAK6 Investments sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 15,626 shares — an estimated $360K sold.

PEAK6 Investments first reported a position in PRVA in Q2 2022 and held it in 6 quarters. The position peaked at $661K in Q4 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • PEAK6 Investments reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 15,626 Privia Health shares in Q1 2024, an estimated $360K.
  • PEAK6 Investments first reported a position in Privia Health in Q2 2022 and held it in 6 quarters.
  • PEAK6 Investments's Privia Health position peaked at $661K in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.